title: Blood containing high levels of antibodies to heat shock protein 65 (hsp65) were found to be at increased risk of subsequent cardiovascular events.
authors.forename: Ruth
authors.initials: R
authors.lastname: SoRelle
mesh_terms: D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood*; D001426:Bacterial Proteins; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology*; D018834:Chaperonin 60; D018833:Chaperonins / Q000276:immunology*; D002784:Cholesterol / Q000276:immunology*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D003169:Complement Inactivator Proteins / Q000627:therapeutic use; D001026:Coronary Artery Bypass / Q000592:standards / Q000639:trends; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005374:Filtration / Q000295:instrumentation / Q000379:methods; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D009369:Neoplasms / Q000139:chemically induced; D010353:Patient Education as Topic / Q000379:methods / Q000458:organization & administration; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015607:Stents / Q000009:adverse effects
chemical_list: D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D001323:Autoantibodies; D001426:Bacterial Proteins; D018834:Chaperonin 60; D003169:Complement Inactivator Proteins; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; C074119:heat-shock protein 65, Mycobacterium; D002784:Cholesterol; D018833:Chaperonins